<DOC>
	<DOCNO>NCT01126619</DOCNO>
	<brief_summary>In recent year , biologics change treatment psoriasis , give u additional therapeutic option potentially less toxic liver , kidney , bone marrow teratogenic . Nevertheless , traditional systemic therapy continue play important role treatment psoriasis Turkey , even patient require biologic treatment accord national recommendation . This study designate observe effectiveness safety tumor necrosis factor inhibitor patient moderate severe psoriasis .</brief_summary>
	<brief_title>A Study Effectiveness Safety Tumor Necrosis Factor ( TNF ) Inhibitors Patients With Moderate Severe Psoriasis</brief_title>
	<detailed_description>Patients admit dermatology clinic , moderate severe psoriasis physician decide initiate psoriasis treatment anti-TNFs accordance Turkish Ministry Health regulation reimbursement . ( Tumor necrosis factor inhibitor use treatment moderate severe chronic plaque psoriasis adult patient fail respond contraindication , intolerant systemic therapy include cyclosporine , methotrexate Psoralen Ultra-Violet A . Patients screen latent tuberculosis appropriate anti-tuberculosis prophylaxis must initiate latent tuberculosis diagnose ) . This national , multi-center , observational , prospective photographic atlas study patient treat tumor necrosis factor inhibitor moderate severe psoriasis daily clinic accord Turkish regulation reimbursement . Demographic data collect investigator begin study . Every participant examine investigator Psoriasis Area Severity Index determine begin study week 4 , 8 , 16 24 . Each patient ask fill Dermatology Life Quality Index visit . Each patient ask fill Work Productivity Activity Impairment Questionnaire : Psoriasis begin last visit ( week 24 ) . A standardized set photograph take begin study week 4 , 8 , 16 24 dermatologist train standardized photograph position setting . Psoriasis Area Severity Index , Dermatology Life Quality Index Photographic score statistically analyze separately order evaluate treatment response .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male female patient â‰¥18 year old moderatetosevere psoriasis . Patients physician decide initiate psoriasis treatment antiTNFs accordance Turkish Ministry Health regulation reimbursement . Patients able understand answer self administer questionnaire . Patients sign informed consent form state agree photograph take , analyze , include scientific publication . Patients consent photograph study . Females pregnant , nursing , childbearing potential refuse use medically acceptable form contraception throughout study . Patients untreated tuberculosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>